Search results
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer...
Benzinga· 5 days agoOn Friday, Pfizer Inc PFE released longer-term follow-up results from the Phase 3 CROWN trial...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 2 days agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
How To Earn $500 A Month From Pfizer Stock
Benzinga· 5 days agoShares of Pfizer Inc. PFE closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer recently...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward
Reuters· 2 days agoShares of British drugmaker GSK dropped more than 9% on Monday, after a Delaware judge allowed more...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
New U.S. bird-flu case is first with respiratory symptoms, CDC says
Market Watch· 6 days agoA new human bird-flu case identified in a Michigan dairy worker is the first in the U.S. to involve...
EU regulator recommends use of Pfizer's gene therapy for rare bleeding disorder
Reuters· 5 days agoThe European Medicines Agency has recommended the use of Pfizer's gene therapy for a rare bleeding...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 4 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Moderna wins second product approval with RSV vaccine
Market Watch· 5 days agoThe Food and Drug Administration approved the mRNA shot, mResvia, for adults 60 and older,...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters· 5 days ago, opens new tab said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030...